95
Views
20
CrossRef citations to date
0
Altmetric

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Miki Sato, Shinichi Kako, Kumi Oshima, Ken Sato, Kiriko Terasako, Shun-Ichi Kimura, Hideki Nakasone, Shinya Okuda, Rie Yamazaki, Takakazu Higuchi, Junji Nishida & Yoshinobu Kanda. (2010) Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia. Scandinavian Journal of Infectious Diseases 42:2, pages 97-101.
Read now
Cristina Prat, Juan Manuel Sancho, Josep Domínguez, Blanca Xicoy, Montse Giménez, Christelle Ferrà, Silvia Blanco, Alicia Lacoma, Josep Maria Ribera & Vicenç Ausina. (2008) Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leukemia & Lymphoma 49:9, pages 1752-1761.
Read now
Sari Hämäläinen, Taru Kuittinen, Irma Matinlauri, Tapio Nousiainen, Irma Koivula & Esa Jantunen. (2008) Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences. Leukemia & Lymphoma 49:3, pages 495-501.
Read now
Lennart Persson, Per Engervall, Anders Magnuson, Tomas Vikerfors, Bo Söderquist, Lars-olof Hansson & Ulf Tidefelt. (2004) Use of Inflammatory Markers for Early Detection of Bacteraemia in Patients with Febrile Neutropenia. Scandinavian Journal of Infectious Diseases 36:5, pages 365-371.
Read now

Articles from other publishers (16)

Karin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, Judith Feucht, Patrick Schlegel, Markus Dobratz, Christian Seitz, Ingo Müller, Peter Lang, Rupert Handgretinger & Michaela Döring. (2019) Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients. Journal of Cancer Research and Clinical Oncology 145:11, pages 2779-2791.
Crossref
Ana Madera Rojas, Sonia Cuervo Maldonado, Ricardo Sánchez, Julio Gómez Rincón & Carlos Bermúdez. (2017) Cuantificación de citoquinas y su relación con la presencia de bacteriemia en leucemias agudas y neutropenia febril postquimioterapia. Revista Colombiana de Cancerología 21:3, pages 152-159.
Crossref
Karin G.E. Miedema, Clementien L. Vermont, Lynne M. Ball, Eveline S.J.M. de Bont, Willem A. Kamps, Maarten J.D. van Tol, Cornelia M Jol-van der Zijde & Wim J.E. Tissing. (2014) The Diagnostic Value of Interleukin-8 for the Detection of Bacteremia in Pediatric Hematopoietic Stem Cell Recipients With Febrile Neutropenia. Transplantation 98:8, pages e80-e81.
Crossref
Victor M. Aquino, Carrye Cost, Ana Gomez, Daniel C. Bowers, Octavio Ramilo, Naveed Ahmad, Naomi Winick & Patrick J. Leavey. (2012) Predictive Value of Interleukin-5 and Monocyte Chemotactic Protein-1 for Bacteremia in Children With Febrile Neutropenia. Journal of Pediatric Hematology/Oncology 34:6, pages e241-e245.
Crossref
Shin Ahn, Yoon-Seon Lee, Yun-Hee Chun, In-Ho Kwon, Won Kim, Kyung Soo Lim, Tae Won Kim & Kyoo-Hyung Lee. (2010) Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Supportive Care in Cancer 19:8, pages 1151-1158.
Crossref
John R. Wingard. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases 105 111 .
C.-J. Lin, C.-J. Wu, C.-F. Pan, Y.-C. Chen, F.-J. Sun & H.-H. Chen. (2010) Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrology Dialysis Transplantation 25:11, pages 3693-3700.
Crossref
Kuan-Ting Liu, Tzeng-Jih Lin & Hon-Man Chan. (2008) Characteristics of Febrile Patients with Normal White Blood Cell Counts and High C-Reactive Protein Levels in an Emergency Department. The Kaohsiung Journal of Medical Sciences 24:5, pages 248-253.
Crossref
Anastasia Antoniadou & Helen Giamarellou. (2007) Fever of Unknown Origin in Febrile Leukopenia. Infectious Disease Clinics of North America 21:4, pages 1055-1090.
Crossref
Gulten Secmeer, Ilker Devrim, Ates Kara, Mehmet Ceyhan, Bulent Cengiz, Tezer Kutluk, Munevver Buyukpamukcu, Sevgi Yetgin, Murat Tuncer, Ali Kerem Uludag, Hasan Tezer & Inci Yildirim. (2007) Role of Procalcitonin and CRP in Differentiating a Stable From a Deteriorating Clinical Course in Pediatric Febrile Neutropenia. Journal of Pediatric Hematology/Oncology 29:2, pages 107-111.
Crossref
S. Schuttrumpf, L. Binder, T. Hagemann, D. Berkovic, L. Trumper & C. Binder. (2006) Utility of Procalcitonin Concentration in the Evaluation of Patients with Malignant Diseases and Elevated C-Reactive Protein Plasma Concentrations. Clinical Infectious Diseases 43:4, pages 468-473.
Crossref
C-K Min, S Y Kim, K S Eom, Y J Kim, H J Kim, S Lee, D W Kim, J W Lee, W S Min & C C Kim. (2006) Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse. Bone Marrow Transplantation 37:5, pages 493-498.
Crossref
Lennart Persson, Bo Soderquist, Per Engervall, Tomas Vikerfors, Lars-Olof Hansson & Ulf Tidefelt. (2005) Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. European Journal of Haematology 74:4, pages 297-303.
Crossref
L. Simon, F. Gauvin, D. K. Amre, P. Saint-Louis & J. Lacroix. (2004) Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 39:2, pages 206-217.
Crossref
R Schots, I Van Riet, T Ben Othman, F Trullemans, M De Waele, B Van Camp & L Kaufman. (2002) An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplantation 30:7, pages 441-446.
Crossref
Winfried V. Kern. (2001) Risk assessment and risk-based therapeutic strategies in febrile neutropenia. Current Opinion in Infectious Diseases 14:4, pages 415-422.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.